Bright Minds Biosciences Inc (DRUG)
Cost of Revenue
$40.10K
TTM · Period ending: · CAD
DRUG Cost of Revenue
Latest reported$40.10K CADperiod ending
Latest reported$40.10K CADperiod ending
DRUG TTM Cost of Revenue · CAD ($0.00 → $40.10K)
TTM cost of revenue
High-resolution chart · PNG
DRUG cost of revenue history
Trailing twelve months (TTM) · CAD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (CAD) |
|---|---|
| 40,103 | |
| 20,130 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |